SEC CIK 1632346
Haraf William S
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| SCHWview stock → | 34,555 | 2022-05-19 |
Position History — SCHW
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — SCHW
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2022-05-19 | Grant / award (derivative) | 4,703 | $0.00 | 4,703 |
| 2022-05-19 | Grant / award | 2,054 | $0.00 | 34,555 |
| 2021-05-28 | Option exercise (derivative) | 7,835 | $0.00 | 0 |
| 2021-05-28 | Open-market sale | 7,835 | $73.96 | 32,501 |
| 2021-05-28 | Option exercise | 7,835 | $31.21 | 40,336 |
| 2021-05-17 | Grant / award (derivative) | 4,390 | $0.00 | 4,390 |
| 2021-05-17 | Grant / award | 1,529 | $0.00 | 32,501 |
| 2021-02-16 | Option exercise (derivative) | 7,866 | $0.00 | 0 |
| 2021-02-16 | Open-market sale | 7,866 | $61.25 | 30,972 |
| 2021-02-16 | Option exercise | 7,866 | $28.96 | 38,838 |
| 2020-05-14 | Grant / award (derivative) | 6,655 | $0.00 | 6,655 |
| 2020-05-14 | Grant / award | 3,396 | $0.00 | 30,972 |
| 2019-05-17 | Grant / award (derivative) | 8,584 | $0.00 | 8,584 |
| 2019-05-17 | Grant / award | 3,567 | $0.00 | 27,576 |
| 2018-05-17 | Grant / award (derivative) | 5,139 | $0.00 | 5,139 |
| 2018-05-17 | Grant / award | 2,617 | $0.00 | 24,009 |
| 2017-05-18 | Grant / award (derivative) | 7,165 | $0.00 | 7,165 |
| 2017-05-18 | Grant / award | 3,531 | $0.00 | 21,392 |
| 2016-05-19 | Grant / award (derivative) | 7,866 | $0.00 | 7,866 |
| 2016-05-19 | Grant / award | 4,652 | $0.00 | 17,861 |
| 2016-01-20 | Open-market buy | 4,000 | $25.44 | 13,209 |
| 2015-08-12 | Open-market buy | 3,000 | $33.12 | 9,209 |
| 2015-05-15 | Grant / award (derivative) | 7,835 | $0.00 | 7,835 |
| 2015-05-15 | Grant / award | 3,209 | $0.00 | 6,209 |
| 2015-04-24 | Open-market buy | 3,000 | $30.29 | 3,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.